Join the Afluria group to help and get support from people like you.
Afluria News (Page 2)
In Good News for U.S., Flu Vaccine Working Well in South America
MONDAY, Sept. 11, 2023 – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South A...
Recommendations Updated for Flu Vaccine in Children
TUESDAY, Aug. 29, 2023 – Recommendations have been updated for influenza vaccination among U.S. children for the 2023 to 2024 season, according to a policy statement and accompanying technical...
Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk
MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...
Gene Changes Made This Season's Bird Flu More Severe
FRIDAY, June 2, 2023 – Genetic mutations caused this latest bird flu season to become more severe, increasing the risk it poses to humans and other mammals, a new study finds. The H5N1 avian...
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...
Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...
Ask a question
To post your own question to this support group, sign in or create an account.